Bad Precedent? Plan B Rx/OTC Labeling May Have Implications For Existing OTCs ­– NEJM
This article was originally published in The Pink Sheet Daily
Executive Summary
Nonprescription drugs, such as aspirin and ibuprofen, could be reevaluated if Barr chooses simultaneous Rx/OTC marketing of levonorgestrel at the same dose for both populations.